Board of Directors of Intrexon Corporation (NYSE:XON) accepted the resignation of Thomas D. Reed from his position as director. Dr. Reed will continue to serve as Chief Science Officer of the Company. To fill the vacancy on the Board left by Dr. Reed’s resignation and upon recommendation of its Nominating and Governance Committee, the Board appointed James S. Turley as a non-employee director of the Company. Intrexon Corp(NYSE:XON) shares after opening at $18.20 moved to $18.30 on last trade day and at the end of the day closed at $18.00. Company price to sales ratio in past twelve months was calculated as 74.75 and price to cash ratio as 10.02. Intrexon Corp (NYSE:XON) showed a negative weekly performance of -3.28%.
XenoPort (NASDAQ:XNPT)‘s stock had its “buy” rating reiterated by equities researchers at Jefferies Group in a research report issued on Tuesday, Analyst RN reports. They currently have a $6.00 price objective on the stock. Jefferies Group’s price objective suggests a potential upside of 47.78% from the stock’s previous close. XenoPort, Inc. (NASDAQ:XNPT) shares fell -1.05% in last trading session and ended the day on $3.76. XNPT return on equity ratio is recorded as -107.50% and its return on assets is -80.10%. XenoPort, Inc. (NASDAQ:XNPT) yearly performance is -32.26%.
Investment analysts at Jefferies Group initiated coverage on shares of Corium International (NASDAQ:CORI) in a note issued to investors on Monday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $13.00 price target on the stock. Jefferies Group’s price objective suggests a potential upside of 74.03% from the stock’s previous close. Corium International Inc (NASDAQ:CORI) shares moved down -1.74% in last trading session and was closed at $7.34, while trading in range of $ 7.00 – 7.34. Corium International Inc (NASDAQ:CORI) year to date (YTD) performance is -8.25%.
Vital Therapies (NYSE:VTL) Director Muneer A. Satter acquired 360,966 shares of the stock in a transaction dated Wednesday, April 23rd. The shares were purchased at an average cost of $12.00 per share, with a total value of $4,331,592.00. Vital Therapies Inc(NASDAQ:VTL) weekly performance is -3.74%. On last trading day company shares ended up $12.10. Vital Therapies Inc(NASDAQ:VTL) distance from 50-day simple moving average (SMA50) is -1.71%.